GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (STU:U5P) » Definitions » Land And Improvements

Vivani Medical (STU:U5P) Land And Improvements : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical Land And Improvements?

Vivani Medical's land and improvements for the quarter that ended in Mar. 2025 was €0.00 Mil.


Vivani Medical Land And Improvements Historical Data

The historical data trend for Vivani Medical's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivani Medical Land And Improvements Chart

Vivani Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Land And Improvements
- - - - -

Vivani Medical Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vivani Medical Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Vivani Medical Business Description

Traded in Other Exchanges
Address
1350 South Loop Road, Alameda, CA, USA, 94502
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Vivani Medical Headlines

No Headlines